References
- Collins PL, Chanock RM, Murphy BR. Respiratory Syncytial Virus. Fields Virology4th edn, DM Knipe, PM Howley. Lippencott-Raven Publishers, Philadelphia 2001; 1443–85
- Selwyn BJ. The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Coordinated Data Group of BOSTID Researchers. Rev Infect Dis 1990; 12(Suppl 8)S870–88
- Glezen P, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973; 288: 498–505
- Division of Health Promotion and Disease Prevention IoMWU New Vaccine Development. Establishing Priorities. New Vaccine Development 1985;1:397–410.
- Meissner HC. Economic impact of viral respiratory disease in children. J Pediatr 1994; 124: S17–21
- Leader S, Kohlhase K. Respiratory syncytial virus-coded paediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J 2002; 21: 629–32
- Kristensen K, Dahm T, Frederiksen PS, Ibsen J, Iyore E, Jensen AM, et al. Epidemiology of respiratory syncytial virus infection requiring hospitalization in East Denmark. Pediatr Infect Dis J 1998; 17: 996–1000
- The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102: 531–7
- Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH, Jr, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with haemodynamically significant congenital heart disease. J Pediatr 2003; 143: 532–40
- Ulrik CS, Backer V. Atopy in Danish children and adolescents: results from a longitudinal population study. Ann Allergy Asthma Immunol 2000; 85: 293–7
- Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 1999; 282: 1440–6
- Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis 2004; 189: 233–8
- Sampalis JS. Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants. J Pediatr 2003; 143(Suppl 5)S150–6
- Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003; 143(Suppl 5)S127–32
- Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997. J Infect Dis 2001; 183: 16–22
- Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263–8
- Pedersen M, Klarlund M, Jacobsen S, Svendsen AJ, Frisch M. Validity of rheumatoid arthritis diagnoses in the Danish National Patient Registry. Eur J Epidemiol 2004; 19: 1097–103
- Devantier A, Kjer JJ. The national patient register – a research tool?. Ugeskr Laeger 1991; 153: 516–7
- Nielsen HW, Tuchsen F, Jensen MV. Validity of the diagnosis ‘essential hypertension’ in the National Patient Registry. Ugeskr Laeger 1996; 158: 163–7
- Fonager K, Sorensen HT, Rasmussen SN, Moller-Petersen J, Vyberg M. Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system. Scand J Gastroenterol 1996; 31: 154–9
- Boivin G, Cote S, Dery P, De SG, Bergeron MG. Multiplex real-time PCR assay for detection of influenza and human respiratory syncytial viruses. J Clin Microbiol 2004; 42: 45–51